IP Library Granted Patent US 8,263,774
Granted Patent B2
US 8,263,774 · App. 12/553,352 · Granted Sep 11, 2012

Quinoline-oxazoline compounds and their use in oxidation synthesis

Assignee: University of Utah Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,263,774
App. No.
12/553,352
Granted
Sep 11, 2012
Kind
B2
Abstract

A quinoline-oxazoline compound having the formula: where one of X 1 and X 2 is N and the other is C and one of R1, R2 and R3 is Z wherein Z is an oxazoline radical having the formula such that when X 1 is N R2 is Z and R1 is absent, and when X 2 is N either R1 or R3 is Z and R2 is absent. R1 and R3 through R12 are independently H or a pendant moiety which does not interfere with coordination of either N in the quinoline compound with a coordination center. These compounds can be complexed with a suitable coordination center such as catalytically active palladium and can be highly useful in catalytically oxidizing alkenes with high regioselectivity.

Claims (27)

1. A method of catalytically oxidizing an alkene, comprising:

a) exposing an alkene to a quinoline catalyst complex in the presence of a mediation compound to form a ketone, said quinoline catalyst complex including a coordination center complexed with a quinoline compound having the formula

where one of X 1 and X 2 is an N and the other is C and one of R1, R2 and R3 is Z wherein Z is an oxazoline having the formula

such that when X 1 is N R2 is Z and R1 is absent, and when X 2 is N either R1 or R3 is Z and R2 is absent, and R1 and R3 through R12 are independently H or a pendant moiety which does not interfere with coordination of either N in the quinoline compound with the coordination center.

2. The method of claim 1 , wherein the quinoline compound is a quinoline-2-oxazoline having the formula:

3. The method of claim 2 , wherein R3 through R12 are hydrogen.

4. The method of claim 2 , wherein R3 through R8, R11 and R12 are hydrogen and R9 and R10 are methyl.

5. The method of claim 1 , wherein the quinoline compound is a 1-isoquinolineoxazoline having the formula:

6. The method of claim 5 , wherein R3 through R12 are hydrogen.

7. The method of claim 1 , wherein the quinoline compound is a 3-isoquinolineoxazoline having the formula:

8. The method of claim 7 , wherein R1 and R4 through R12 are hydrogen.

9. The method of claim 1 , wherein R1 and R3 through R12 are independently selected from the group consisting of hydrogen, lower alkyl, aryl, and halide.

10. The method of claim 9 , wherein R1 and R3 through R12 are each hydrogen.

11. The method of claim 9 , wherein at least one of R1 and R3 through R12 is methyl.

12. The method of claim 11 , wherein R9 and R10 are methyl.

13. The method of claim 9 , wherein at least one of R1 and R3 through R12 is a lower alkyl having up to 8 carbon atoms.

14. The method of claim 9 , wherein at least one of R1 and R3 through R12 is aryl.

15. The method of claim 9 , wherein at least one of R1 and R3 through R12 is a halide selected from the group consisting of fluorine, chlorine and bromine.

16. The method of claim 1 , wherein the quinolone catalyst complex further comprising the coordination center coordinated with each of the N in the quinoline compound.

17. The method of claim 16 , wherein the coordination center is a metal.

18. The method of claim 17 , wherein the metal is palladium, platinum, rhodium or nickel.

19. The method of claim 18 , wherein the palladium is palladium (II).

20. A quinoline compound having the formula:

wherein R1 and R4 through R12 are hydrogen.

21. A quinoline compound having the formula:

where one of X 1 and X 2 is an N and the other is C and one of R1, R2 and R3 is Z wherein Z is an oxazoline radical having the formula

such that when X 1 is N R2 is Z and R1 is absent, and when X 2 is N either R1 or R3 is Z and R2 is absent, and R1 and R3 through R12 are independently H or a pendant moiety which does not interfere with coordination of either N in the quinoline compound with a coordination center and at least one of R1 and R3 through R12 is a halide selected from the group consisting of fluorine, chlorine and bromine.

Assignments (4)
CONFIRMATORY LICENSE Recorded Jun 10, 2016
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038955/0269 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2009
From: SIGMAN, MATTHEW SCOTT; MICHEL, BRIAN WILLIAM
To: UNIVERSITY OF UTAH
Reel/Frame 023424/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 26, 2009
From: UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 023424/0312 →
CONFIRMATORY LICENSE Recorded Oct 9, 2009
From: UNIVERSITY OF UTAH
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 023351/0728 →
Continuity (1)
Related Publication 20110054176A1 · Mar 3, 2011